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Abstract: PURPOSE: Long-term impairment of quality of life (QoL) occurs in a subset of meningioma
patients, even after curative surgical resection. We sought to explore socioeconomic burden of menin-
gioma surgery and associations with post-operative QoL to identify patients at risk for inferior outcome.
METHODS: All patients with histological diagnosis of an intracranial meningioma treated at a single
institution 2000-2013 were screened for inclusion in this cross-sectional survey study. Surveys comprised
tools to assess socioeconomic status including social deprivation, QoL and symptom burden. Multivariate
binary regression models controlling for established prognostic factors were applied to explore associations
of socioeconomics with QoL 1 year after surgery. RESULTS: Completed surveys were returned by 249
patients. The median age at diagnosis was 56 years (SD ± 12), 185 patients (74%) were female and 219
(88%) had World Health Organization grade I meningiomas. One year after surgery, there was a 20%
decrease in the number of patients working (p < 0.001), 22% of full-time working patients transitioned to
part-time work (p < 0.001) and more patients depended on professional care (14% versus 4%, p < 0.001).
Patients reported improved QoL, including improved global health (effect: 21%, 95% confidence interval
[1] 15-26%), headaches (effect: 19%, CI 13-24%) and seizures (effect: 12%, CI 8-17%). On multivariable
analyses, QoL after meningioma surgery was associated with preoperative employment status (odds ratio
[OR] 0.41, 95% CI 0.17-0.98) and subjective work ability (OR 0.37, 95% CI 0.15-0.92). CONCLUSION:
In a subset of meningioma patients, there is marked socioeconomic burden, which may be associated with
inferior patient-reported outcome.
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Abstract 1 
Purpose: Long-term impairment of quality of life (QoL) occurs in a subset of meningioma patients, 2 





surgery and associations with post-operative QoL, seeking to identify patients at risk for inferior 4 
outcome. 5 
Methods: All patients with histological diagnosis of an intracranial meningioma treated at a single 6 
institution 2000-2013 were screened for inclusion in this cross-sectional survey study. Surveys 7 
comprised tools to assess socioeconomic status including social deprivation, QoL and symptom 8 
burden. Multivariate binary regression models controlling for established prognostic factors were 9 
applied to explore associations of socioeconomics with QoL one year after surgery. 10 
Results: Completed surveys were returned by 249 patients. The median age at diagnosis was 56 11 
years (SD +/-12), 185 patients (74%) were female and 219 (88%) had World Health Organization 12 
grade I meningiomas. One year after surgery, there was a 20% decrease in the number of patients 13 
working (p<0.001), 22% of full-time working patients transitioned to part-time work (p<0.001) 14 
and more patients depended on professional care (14% versus 4%, p<0.001). Patients reported 15 
improved QoL, including improved global health (effect: 21%, 95% confidence interval [1] 15-16 
26%), headaches (effect: 19%, CI 13-24%) and seizures (effect: 12%, CI 8-17%). On multivariable 17 
analyses, QoL after meningioma surgery was associated with preoperative employment status 18 
(odds ratio [OR] 0.41, 95% CI 0.17-0.98) and subjective work ability (OR 0.37, 95% CI 0.15-0.92). 19 
Conclusions: In a subset of meningioma patients, there is marked socioeconomic burden, which 20 
may be associated with inferior patient-reported outcome. 21 






The clinical course of meningioma patients is often benign and treatment intensity moderate, 24 
comprising neurosurgery alone in most cases [1, 2]. Quality of life and symptom burden improve 25 
after meningioma resection in the majority of patients, including a reduction in pain and discomfort 26 
or anxiety [3-5], but a subset of meningioma patients experience a long-term decrease in quality of 27 
life [3, 6, 7], particularly in the social and emotional functioning domains [7, 8]. Factors associated 28 
with post-operative quality of life include age, symptom burden, histological tumor grade, tumor 29 
size and extent of resection [4, 7].  30 
Associations of lower socioeconomic status with unfavorable outcome has been reported from 31 
pediatric and unselected brain tumor patients [9, 10], but in meningioma patients, putative 32 
interactions of socioeconomics with quality of life have not been studied in detail. 33 
To explore this possibility, we conducted a cross-sectional survey study in a clinically well-34 
characterized cohort of meningioma patients. The primary objective of our study was to address 35 
the question whether or not socioeconomics should be assessed along with quality of life in 36 
prospective studies of meningioma and potentially other brain tumor patients. A more thorough 37 
understanding of the factors that determine quality of life will eventually improve the identification 38 
and supportive care of patients at risk for deterioration of quality of life. 39 
Patients and methods 40 
Subject selection and study design 41 
This cross-sectional survey study was approved by the local ethics committee and was performed 42 
in accordance with the Declaration of Helsinki (IRB No. 2015-00130). Figure 1 details the primary 43 
analysis population. All patients with histologically confirmed intracranial meningioma treated at 44 
the University Hospital Zurich between 2000-2013 and with a follow-up of at least 1 year were 45 
screened for inclusion. The analysis period was determined by the introduction of an electronic 46 
chart system at this institution in the year 2000. Among 729 patients matching these criteria, 320 47 





either lost to follow-up (N=196) or had died (N=124). Surveys were sent to all 409 eligible patients 49 
in August 2016 to retrospectively explore their quality of life and socioeconomic status. 50 
Subject information and consent 51 
Patients who were still alive were informed that his/her medical records may be examined by 52 
authorized individuals other than their treating physician. Along with questionnaires on quality of 53 
life and socioeconomic parameters, patients and their general practitioners received a subject 54 
information sheet which explained the nature of the study and its purpose. Each subject was 55 
informed that the participation in the study is voluntary and that he/she may withdraw from the 56 
study at any time and that withdrawal of consent will not affect his/her subsequent medical 57 
treatment.  58 
Return of questionnaires by patients was considered consent with the further use of the data 59 
provided by the patient. Concerning the further use of already available clinical data that were 60 
obtained from the patients’ general practitioners, the lack of refusal of further use of their clinical 61 
data by the patient was considered consent. In the case of patients who have died or who were 62 
unable to respond or who were lost to follow-up, no consent was sought in accordance with local 63 
legislation for the following reasons: (1) In a majority of patients the tumor resection dated back 64 
several years, thus making it impossible or disproportionately difficult to obtain consent or to 65 
provide information on the right to dissent. (2) The interests of research outweigh the interests of 66 
the person concerned in deciding on the further use of his or her data, because results from the 67 
planned analyses were likely to have immediate implications for future patients. 68 
Variables 69 
Demographics and clinical data have been annotated and defined previously [11, 12]. Surveys were 70 
sent to eligible patients in April 2016 and comprised level of education, profession, employment 71 
status, subjective work ability, monthly income, an eleven-item socioeconomic assessment tool to 72 
quantify material and social deprivation (EPICES, Evaluation of deprivation and health inequalities 73 
in healthcare clinics) [13], quality of life utilizing the European Organization for Research and 74 
Treatment of Cancer (EORTC) quality of life questionnaire C30 (QLQ-C30) and brain tumor 75 
module BN20 [14], and symptom burden utilizing the MD Anderson Symptom Inventory Brain 76 





material and social deprivation. A score of 30 or higher corresponds to relevant deprivation [16]. 78 
The EORTC QLQ-C30 assesses health-related quality of life including global health status, five 79 
functional scales and a number of scales and items assessing additional symptoms commonly 80 
reported by cancer patients [14]. It is supplemented by the EORTC QLQ-BN20 that includes four 81 
functional scales and seven symptom items to additionally assess quality of life parameters of 82 
importance to patients with brain cancer [14]. The MDASI-BT measures the patient reported 83 
symptom burden and interference with daily life by assessing the severity of 13 symptoms and by 84 
adding six questions of interference with different aspects of patients’ life. Symptom items were 85 
grouped into previously defined subcategories, including general/disease-related such as fatigue, 86 
pain, disturbed sleep or change in appearance, as well as affective, cognitive, neurological and 87 
gastrointestinal. 88 
All questionnaires were formally adapted for retrospective interrogation on the time points at 89 
surgery and 1 year after surgery. All scales and items in the EORTC QLQ-C30/BN20 and MDASI-90 
BT were fitted to quasi-continuous scales ranging from 0-100, with higher scores representing 91 
better quality of life and lower symptom burden. The categorical variables “Any clinically 92 
meaningful deterioration in Quality of life” and “Any clinically meaningful increase in symptom 93 
burden” were computed in addition by applying a 10% cut-off to all EORTC QLQ-C30/BN20 or 94 
MDASI-BT scales [14]. 95 
The Charlson comorbidity index (CCI) [17] was applied to quantify comorbid disease burden for 96 
the timepoint of surgery. In order to minimize missing data, items of the CCI retrieved from 97 
patients’ electronic charts were complemented through information obtained from the patients’ 98 
general practitioners. Comorbidities documented neither in the hospital’s electronic chart system 99 
nor reported by patients’ general practitioners were assumed not to be present. The level of 100 
professional care was determined through the patients’ general practitioners.  101 
Statistical methods 102 
SPSS V23.0 (IBM) was utilized for all statistical analyses. The chi-square test was performed for 103 
analysis of nominal variables. The Mann-Whitney U test was performed for ordinal variables and 104 
for interval-scaled variables that were not normally distributed. Non-normality of continuously 105 
scaled variables including quality of life was determined utilizing the Kolmogorov-Smirnov test. 106 





inferior quality of life. Variance inflation factors (VIF) of the regression model were determined 108 
by linear regression to test for multicollinearity, and VIF <5 were defined as no multicollinearity 109 
[18]. Linearity of independent variables was determined by Pearson’s correlation and Nagelkerke’s 110 
R2 test was done to estimate the model fit. No imputation of missing data was done. No sample 111 
size estimation was done. A p-value <0.05 was considered statistically significant for any analyses. 112 
Cronbach’s α-test was applied as a measure of reliability of the applied scores. 113 
Results 114 
Patient characteristics 115 
Completed surveys were obtained from 249 of 409 eligible patients (61%). There were 88 patients 116 
(21%) who did not consent, 48 patients (12%) did not return the survey due to a foreign mother 117 
tongue and 24 patients (6%) due to cognitive impairment. Characteristics of the primary analysis 118 
population are summarized in Table 1. The median age at surgery was 56 years (standard deviation 119 
+/- 12 years) and 185 patients (74%) were female. The high rate of female patients with 120 
meningioma reflects the population-based gender distribution of meningioma [1]. The level of 121 
education was an apprenticeship or higher in 214 patients (86%). The most common professional 122 
background in 100 patients (40%) was employee, followed by leadership or academia in 49 patients 123 
(20%) and 40 patients (16%) were industrial or agricultural workers. Relevant comorbidities 124 
indicated by a CCI larger than 2 were present in 57 patients (23%). The vast majority of 219 patients 125 
(88%) suffered from WHO grade I meningiomas. The most common tumor location was the skull 126 
base in 89 patients (36%), followed by convexity meningiomas in 54 (22%). A radiographic gross 127 
total resection was achieved in 189 patients (76%). Ninety-nine patients (40%) suffered from any 128 
neurological deficit one year after surgery, and 31 (12%) experienced a recurrence of their 129 
meningioma during this time. Patients who did not return surveys (N=160) compared to the primary 130 
analysis population had a higher frequency of tumor recurrences one year after surgery (22%, 131 
p=0.009). There was also a trend towards higher age at surgery (p=0.059), higher WHO grade 132 
(p=0.085) and a lower rate of radiographic gross total resections (p=0.065), whereas no difference 133 
was detected with respect to gender distribution (p=0.24), tumor location (p=0.19) or presence of 134 
neurological deficits at 1 year after surgery (p=0.39, Table S1).  135 





Socioeconomic parameters before and 1 year after meningioma surgery are summarized in Table 137 
2. There were 47 fewer patients (20%) working, including 13 patients (5%) who were unemployed, 138 
11 patients (5%) who were disabled, and 23 patients (10%) who had retired due to age (p<0.001). 139 
Of 101 patients working fulltime before surgery, 21 patients (21%) had transitioned to part-time 140 
work and 24 patients (24%) had stopped working. Among 88 patients working part-time before 141 
surgery, 23 patients (26%) had stopped working. This led to an overall decrease in the patients 142 
working full time while the absolute number of patients working part time remained stable. The 143 
monthly income was unaffected in the higher income segments over 8.000 CHF per month, but 11 144 
patients (7%) had shifted into the lowest income segment below 4.000 CHF per month (p=0.008), 145 
which is in the range of the guaranteed basic social security. There were 21 more patients (10%) 146 
who required professional care (p<0.001), which was administered as home nursing in all but 2 147 
patients (1%). 148 
Quality of life 1 year after surgery versus before surgery 149 
Figure 2A summarizes changes in quality of life before versus one year after surgery of an 150 
intracranial meningioma. A clinically meaningful improvement one year after surgery was 151 
observed in individual scales of the EORTC-QLQ-C30/BN20 (defined as a >10% shift, see 152 
methods) for global health (20.7%, 95% confidence interval [1] 15.2-26.2%), headaches (18.6%, 153 
95% CI 13.6-23.6%) and seizures (12.1%, 95% CI 7.7-16.5%). There was also a <10% 154 
improvement of emotional and social functioning, future uncertainty and of several symptom items, 155 
including nausea and vomiting, pain, appetite loss, visual disorder and motor dysfunction, whereas 156 
no worsening of any scale was observed on the population level. The MDASI-BT did not determine 157 
>10% changes in symptom burden or interference, albeit lower level improvement was noted for 158 
all scales but cognitive functioning (Figure 2B). On the patient level worsening in one or more 159 
scales of the EORTC-QLQ-C30/BN20 or the MDASI-BT one year after surgery has been reported 160 
by 178 patients (71.5%). The score reliability was confirmed for both, the EORTC-QLQ-161 
C30/BN20 (α = 0.92) and the MDASI-BT (α = 0.93).  162 
Multivariable analyses 163 
We employed a binary regression model to explore predictors of a clinically meaningful decline in 164 





BT one year after surgery (Table 3). The model comprised the variables age (<55 versus >55 years), 166 
gender (female versus male), WHO grade (I versus II/III), tumor location (other versus skull base), 167 
tumor diameter (<40 versus >40 mm) and presence versus absence of any neurological deficits one 168 
year after surgery. There was no multicollinearity (any VIF <5) and no linearity of independent 169 
variables except for a mild association of WHO grade and gender (R=0.15, p=0.018). Univariate 170 
analyses are summarized in Table S2. In the multivariable model, only younger age was associated 171 
with a decline in quality of life (odds ratio [OR] 2.38, 95% confidence interval [CI] 1.20-4.76, 172 
p=0.012).  173 
We then utilized this model to explore associations of socioeconomic parameters at the timepoint 174 
of surgery with inferior outcome of quality of life. There was an association with occupational 175 
status (working versus unemployment or retirement, OR 0.41, 95% CI 0.17-0.98, p=0.049) and 176 
along the same lines a subjective work ability of at least 70% was associated with better outcome 177 
(OR 0.37, 95% CI 0.15-0.92, p=0.033). No associations were identified for level of education 178 
(p=0.95), low income (p=0.30), workload (p=0.77), or social deprivation (p=0.54). 179 
Discussion 180 
This cross-sectional survey study was designed to explore socioeconomic burden and associations 181 
with quality of life in meningioma patients. Our study confirms previous reports on improved 182 
quality of life after meningioma resection in the majority of patients [3, 4, 19-21]. However, 183 
associations of the diagnosis and surgery of an intracranial meningioma with socioeconomic status 184 
changes has not been studied in detail. It was striking that the surgery of meningiomas, i.e. 185 
relatively benign intracranial tumors, was followed by pronounced socioeconomic status changes 186 
in a substantial fraction of patients, including unemployment or increased dependency on care. 187 
Consistent with prior reports, e.g. on patients with multiple sclerosis [22] or a population-based 188 
analysis [23], we have also identified an association of unemployment with inferior quality of life. 189 
Our finding of an association of higher subjective work ability with better quality of life 190 
underscores the relevance of self-efficacy as a source of resilience, especially in younger neuro-191 
oncology patients who appear to be less confident about their cognitive performance after surgery 192 





may have contributed to an overall more pronounced volatility of quality of life among younger 194 
patients in our cohort.  195 
We hypothesize that even more prominent associations of socioeconomics with quality of life may 196 
be present in societies that are lacking a socialized health care system and high social security 197 
standards. Moreover, the question arises whether patients suffering from brain tumors with less 198 
favorable prognosis are likewise affected by the socioeconomic impact of their diagnosis. In fact, 199 
the quality of life of entire families is likely to be affected by the socioeconomic demands of care, 200 
treatment and rehabilitation [15]. Other factors that will probably determine quality of life include 201 
cognitive functioning and the presence of anxiety or depression [5, 7, 20, 25]. Notably, these 202 
psychiatric symptoms are not reflected by the CCI. A trend towards reduced future uncertainty and 203 
better emotional social functioning one year after surgery suggests that surgery may improve these 204 
potential confounders of quality of life, but future prospective studies should be designed to clarify 205 
putative interactions of these factors with socioeconomic burden. 206 
An inherent limitation of the design of our study is random data loss due to unreturned surveys or 207 
return of incomplete surveys, albeit the survey return rate in our study was high, at least in part due 208 
to follow-up phone calls that were performed in patients who did not respond. We did not correct 209 
statistically for multiple testing, as recommended by Bender and Lange (2001) for exploratory 210 
studies in order to avoid false negative results [26]. We also report selection bias of our study 211 
toward patients with a more favorable disease course, including less frequent tumor recurrence, 212 
lower WHO grade and a higher rate of gross total resections. This selection might have led to an 213 
overestimation of improvement of quality of life after surgery, but also implies that socioeconomic 214 
burden may been have been underestimated. The retrospective design of our study implies that 215 
patients’ quality of life at the time-point when the surveys were received has likely corroborated 216 
the results. The key valuation of our study is however unaffected by these limitations, i.e. that 217 
relevant socioeconomic burden is associated with meningioma surgery and that socioeconomics 218 
may confound outcome measures.  219 
Conclusion 220 
Patients with meningioma experience socioeconomic burden, which is associated with inferior 221 





warranted to define and meet public health challenges in meningioma patients more precisely, 223 
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Figure legends 290 
Figure 1. Study population. 291 
Figure 2. Quality of life (A) and symptom burden (B) one year after versus before meningioma 292 
surgery. Forest plots depict effect sizes, defined as differences in mean values on quasi-continuous 293 
scales ranging from 0-100. 294 
Supplemental Digital Content 295 
Supplemental Digital Content 1. Table. Characteristics of patients who returned the surveys versus 296 
patients who did not return the surveys. 297 
Supplemental Digital Content 2. Table. Univariate analyses of inferior quality of life one year after 298 
surgery. 299 
Purpose: Long-term impairment of quality of life (QoL) occurs in a subset of meningioma 
patients, even after curative surgical resection. We sought to explore socioeconomic burden of 
meningioma surgery and associations with post-operative QoL, seeking to identify patients at 
risk for inferior outcome. 
Methods: All patients with histological diagnosis of an intracranial meningioma treated at a 
single institution 2000-2013 were screened for inclusion in this cross-sectional survey study. 
Surveys comprised tools to assess socioeconomic status including social deprivation, QoL and 
symptom burden. Multivariate binary regression models controlling for established prognostic 
factors were applied to explore associations of socioeconomics with QoL one year after surgery. 
Results: Completed surveys were returned by 249 patients. The median age at diagnosis was 
56 years (SD +/-12), 185 patients (74%) were female and 219 (88%) had World Health 
Organization grade I meningiomas. One year after surgery, there was a 20% decrease in the 
number of patients working (p<0.001), 22% of full-time working patients transitioned to part-
time work (p<0.001) and more patients depended on professional care (14% versus 4%, 
p<0.001). Patients reported improved QoL, including improved global health (effect: 21%, 95% 
confidence interval [1] 15-26%), headaches (effect: 19%, CI 13-24%) and seizures (effect: 
12%, CI 8-17%). On multivariable analyses, QoL after meningioma surgery was associated 
with preoperative employment status (odds ratio [OR] 0.41, 95% CI 0.17-0.98) and subjective 
work ability (OR 0.37, 95% CI 0.15-0.92). 
Conclusions: In a subset of meningioma patients, there is marked socioeconomic burden, 
which may be associated with inferior patient-reported outcome. 
 
Table 1. Patient characteristics. 
  






Gender: N (%)  
Female 185 (74) 
Male 64 (26) 
Highest level of education: N (%)  










Profession: N (%)  
Leadership or academic 
Employee 






Charlson Comorbidity Index (CCI): N (%)  
CCI ≤ 2 192 (77) 
CCI 3-4 50 (20) 
CCI ≥ 5 7 (3) 
WHO grade: N (%)  
I 
II / III 
219 (88) 
30 (12) 
Location: N (%)  
Multiple meningiomas 
Convexity 








Other 7 (3) 






















Table 2. Socioeconomics before versus one year after surgery. 
 At surgery One year after surgery  























Workload: N (%)a    
full time 







101 (42)  
<0.001 

















Subjective work ability: 
% c 
   
Mean 73 72 






Care dependency: N (%)d    
No professional care 



















a data available for 243 patients b data available for 166 patients c data available for 
146 patients 
d data available for 223 patients e data available for 176 patients 
f Cronbach’s alpha = 0.96 
 
 
Table 3. Multivariable model of inferior quality of life one year after surgery.# 
  
 Odds ratio and 95% CI p 
Age: <55y versus >55y 2.38 (1.20;4.76) 0.012* 
Gender: female versus male 1.56 (0.77;3.13) 0.22 
WHO grade: I versus II/III 1.16 (0.33;2.50) 0.84 
Location: other versus skullbase 0.67 (0.34;1.33) 0.26 
Diameter: <40mm versus ≥40mm 0.57 (0.29;1.12) 0.11 
Postoperative neurological deficit:  
no versus yes 
0.75 (0.38;1.47) 0.40 
Socioeconomic parameters at diagnosis+   
Highest level of education: Apprenticeship or 
higher versus school or lower 
1.02 (0.50;2.10) 0.95 
Occupation: working versus unemployed or 
retired 
0.41 (0.17;0.98) 0.049* 
Monthly income: >4000 versus <4000 CHF 0.63 (0.26;1.52) 0.30 
Workload: part-time versus full-time 0.88 (0.38;2.03) 0.77 
Subjective work ability: >70 versus <70 %  0.37 (0.15;0.92) 0.033* 
Social deprivation: EPICES <30 versus >30 2.79 (0.98;7.91) 0.54 
# complete datasets were available from 192 patients; + tested as additional single 
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Odds ratio and 95% CI p 
Age: <55y versus >55y 1.56 (0.89;2.75) 0.12 
Gender: female versus male 1.60 (0.86;2.96) 0.14 
WHO grade: I versus II/III 0.95 (0.40;2.24) 0.90 
Location: other versus skullbase 0.70 (0.38;1.30) 0.26 
Diameter: <40mm versus ≥40mm 0.74 (0.41;1.34) 0.32 
Postoperative neurological deficit:  
no versus yes 
0.64 (0.36;1.16) 0.14 
 
Socioeconomic parameters at diagnosis 
  
Highest level of education: Apprenticeship 
or higher versus school or lower 
0.90 (0.49;1.65) 0.74 
Occupation: working versus unemployed or 
retired 
0.64 (0.31;1.33) 0.23 
Monthly income: >4000 versus <4000 CHF 1.10 (0.55;2.22) 0.78 
Workload: part-time versus full-time 1.05 (0.56;1.99) 0.88 
Subjective work ability: >70 versus <70 %  0.56 (0.27;1.19) 0.13 
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Table S1. Characteristics of patients who returned the surveys versus 























WHO grade: N (%)    
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Tumor location: N (%)    
Multiple meningiomas 
Convexity 




























Neurological deficits 1 











Tumor recurrence within 
1 year after surgery: N 
(%) 
   
Yes 
No 
31 (12) 
218 (88) 
125 (26) 
355 (74) 
<0.001 
 


